08/28/2026
What if a vaccine could teach a patient’s immune system to recognize their unique cancer? A positive Phase 3 topline readout suggests that vision may be moving closer to reality.
Understand the significance of this key milestone, and discover what happens next, in our newest blog post: https://bit.ly/4zFS6Rp
New Phase 3 results mark a milestone for personalized mRNA cancer vaccines in melanoma. Learn how they work, what the results mean, and what comes next.